ClinicalTrials.Veeva

Menu

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

A

Ajou University School of Medicine

Status and phase

Completed
Phase 4

Conditions

Acute Coronary Syndrome

Treatments

Drug: generic clopidogrel (Plavitor® )
Drug: original clopidogrel (Plavix® )

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02060786
Plavitor

Details and patient eligibility

About

This study demonstrates the effect of generic clopidogrel bisulfate (Plavitor®) in comparison with the original clopidogrel bisulfate (Plavix®) in patients with acute coronary syndrome.

Enrollment

90 patients

Sex

All

Ages

19 to 74 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with unstable angina or non-ST elevation myocardial infarction
  2. Patients who are planned coronary angiography
  3. Age >18 years, <75 years
  4. Patients who agree to the study protocol

Exclusion criteria

  1. Recent treatment with clopidogrel or pletaal or glycoprotein IIb/IIIa Rc antagonist
  2. Active bleeding (peptic ulcer, trauma or intra-cranial hemorrhage)
  3. Allergy to antiplatelet agent
  4. Bleeding diasthesis (blood coagulation disorders, uncontrolled severe hypertension, history of severe bleeding)
  5. History of drug abuse or alcohol abuse
  6. ST elevation myocardial infarction
  7. Pregnancy
  8. Low platelet count (< 100,000 /L) or abnormal results of PT or PTT
  9. Liver disease ( bilirubin > 2 mg/dL, AST or ALT > 100 IU)
  10. Renal failure ( Cr > 2.0 mg/dL)
  11. Malignancy
  12. Proton pump inhibitor, NSAIDs statin (except atorvastatin)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

original Clopidogrel Bisulfate (Plavix®)
Active Comparator group
Description:
original Clopidogrel Bisulfate (Plavix®) 600mg loading
Treatment:
Drug: original clopidogrel (Plavix® )
generic Clopidogrel Bisulfate (Plavitor®)
Experimental group
Description:
generic Clopidogrel Bisulfate (Plavitor®) 600mg loading
Treatment:
Drug: generic clopidogrel (Plavitor® )

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems